Macrophage-Mediated Delivery of Hypoxia-Activated Prodrug Nanoparticles

被引：2
|
作者：
Evans, Michael A.
Shields, C. Wyatt
Krishnan, Vinu
Wang, Lily Li-Wen
Zhao, Zongmin
Ukidve, Anvay
Lewandowski, Michael
Gao, Yongsheng
Mitragotri, Samir
机构：
来源：
ADVANCED THERAPEUTICS | 2020年 / 3卷 / 11期
关键词：
D O I：
10.1002/adtp.202000183
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
    Jonathan W Wojtkowiak
    Heather C Cornnell
    Shingo Matsumoto
    Keita Saito
    Yoichi Takakusagi
    Prasanta Dutta
    Munju Kim
    Xiaomeng Zhang
    Rafael Leos
    Kate M Bailey
    Gary Martinez
    Mark C Lloyd
    Craig Weber
    James B Mitchell
    Ronald M Lynch
    Amanda F Baker
    Robert A Gatenby
    Katarzyna A Rejniak
    Charles Hart
    Murali C Krishna
    Robert J Gillies
    Cancer & Metabolism, 3 (1)
  • [32] Hypoxia-activated prodrug: an appealing preclinical concept yet lost in clinical translation
    Lindner, Lars H.
    LANCET ONCOLOGY, 2017, 18 (08): : 991 - 993
  • [33] A promising strategy for synergistic cancer therapy by integrating a photosensitizer into a hypoxia-activated prodrug
    Yang, De-Chao
    Yang, Xiao-Zhen
    Luo, Cheng-Miao
    Wen, Lin-Feng
    Liu, Jian-Yong
    Lin, Zhonghui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 243
  • [34] Hypoxic cell killing by SN36506, a novel hypoxia-activated prodrug
    Niemans, R.
    Yaromina, A.
    Theys, J.
    Ashoorzadeh, A.
    Anderson, R.
    Bull, M.
    Guise, C.
    Hsu, H. L.
    Abbattista, M.
    Mowday, A.
    Patterson, A. V.
    Smaill, J. B.
    Dubois, L.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S311 - S311
  • [35] Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
    Wojtkowiak, Jonathan W.
    Cornnell, Heather C.
    Matsumoto, Shingo
    Saito, Keita
    Takakusagi, Yoichi
    Dutta, Prasanta
    Kim, Munju
    Zhang, Xiaomeng
    Leos, Rafael
    Bailey, Kate M.
    Martinez, Gary
    Lloyd, Mark C.
    Weber, Craig
    Mitchell, James B.
    Lynch, Ronald M.
    Baker, Amanda F.
    Gatenby, Robert A.
    Rejniak, Katarzyna A.
    Hart, Charles
    Krishna, Murali C.
    Gillies, Robert J.
    CANCER & METABOLISM, 2015, 3
  • [36] Iridium photosensitizer constructed liposomes with hypoxia-activated prodrug to destrust hepatocellular carcinoma
    Luo, Shuangling
    Liang, Chao
    Zhang, Qianling
    Zhang, Pingyu
    CHINESE CHEMICAL LETTERS, 2023, 34 (04)
  • [37] A pH/Redox Dual-Responsive Nanocarrier for Hypoxia-Activated Prodrug and Anticancer Prodrug in Cancer Treatment
    Ho, Jhin Chen
    Chen, Ching-Yi
    MACROMOLECULAR CHEMISTRY AND PHYSICS, 2024, 225 (09)
  • [38] Iridium photosensitizer constructed liposomes with hypoxia-activated prodrug to destrust hepatocellular carcinoma
    Shuangling Luo
    Chao Liang
    Qianling Zhang
    Pingyu Zhang
    ChineseChemicalLetters, 2023, 34 (04) : 142 - 147
  • [39] Hypoxic cell killing by CP-506, a novel hypoxia-activated prodrug
    Niemans, R.
    Yaromina, A.
    Theys, J.
    Marcus, D.
    Ashoorzadeh, A.
    Abbattista, M.
    Mowday, A.
    Biemans, R.
    Lieuwes, N.
    Deschoemaeker, S.
    Heyerick, A.
    Guise, C.
    Smaill, J. B.
    Patterson, A. V.
    Dubois, L.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1283 - S1284
  • [40] Hypoxia-activated glutamine antagonist prodrug combined with combretastatin A4 nanoparticles for tumor-selective metabolic blockade
    Zheng, Mengfei
    Xu, Hang
    Huang, Yue
    Sun, Jiali
    Zhang, Honglei
    Lv, Zheng
    Liu, Zhilin
    Tang, Zhaohui
    Chen, Xuesi
    JOURNAL OF CONTROLLED RELEASE, 2024, 365 : 480 - 490
12345